Knight Therapeutics buy krebskrebs
Start price
30.11.20
/
50%
€3.50
Target price
30.11.21
€4.00
Performance (%)
5.14%
End price
01.12.21
€3.68
Summary
This prediction ended on 01.12.21 with a price of €3.68. The BUY prediction by krebskrebs finished with a performance of 5.14%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Knight Therapeutics | -3.191% | -3.191% | -1.622% | 1.111% |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% | 65.664% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% | 111.170% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% | 55.883% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% | 67.956% |
Comments by krebskrebs for this prediction
In the thread Knight Therapeutics diskutieren
Buy mit Kursziel 4,0
In the thread Trading Knight Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

